RESEARCH CENTER PHARMACEUTICAL ENGINEERING GMBH: federal contracts won
Federal contracts of $10,000 or more awarded to this company since October 2023 (FY2024), from USAspending.gov. UEI: JMW6R9VB27L9
1contracts won
$733,525total obligated
$733,525median contract
Sep 11, 2026most recent start
Agencies it works for
| Agency | Contracts | Obligated |
|---|---|---|
| Department of Health and Human Services | 1 | $733,525 |
Industries (NAICS)
| NAICS | Contracts | Obligated |
|---|---|---|
| 541714 Research and Development in Biotechnology (except Nanobiotechnology) | 1 | $733,525 |
Recent contracts
| Contract | Winner | Agency | Obligated | Start |
|---|---|---|---|---|
| NEXT GENERATION PROCESS DEVELOPMENT AND QUALITY CONTROL IN PROTEIN LYOPHILIZATION USING MECHANISTIC AND AI APPROACHES
75F40126C00098 · NAICS 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
— | Department of Health and Human Services Food and Drug Administration |
$733,525 | Sep 11, 2026 Ends: Sep 10, 2028 |
Source: USAspending.gov (prime contract awards of $10,000 or more). Values are amounts obligated to date. Recent months can still change as agencies report late.